Chemours › Financials
Ten years from Chemours’ own SEC filings. Fiscal years end in December.
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.40B | $6.18B | $6.64B | $5.53B | $4.97B | $6.34B | $6.83B | $6.08B | $5.78B | $5.81B | $5.80B | — |
| Gross profit | $1.10B | $1.75B | $1.97B | $1.06B | $1.07B | $1.38B | $1.62B | $1.30B | $1.14B | $902.0M | $886.0M | — |
| Net income | $7.0M | $746.0M | $995.0M | −$52.0M | $219.0M | $608.0M | $578.0M | −$253.0M | $69.0M | −$386.0M | −$304.0M | — |
| Earnings per share, diluted | $0.04 | $3.91 | $5.45 | −$0.32 | $1.32 | $3.60 | $3.65 | −$1.70 | $0.46 | −$2.57 | — | — |
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $902.0M | $1.56B | $1.20B | $943.0M | $1.10B | $1.45B | $1.10B | $1.20B | $713.0M | $670.0M | — | $671.0M |
| Total assets | $6.06B | $7.29B | $7.36B | $7.26B | $7.08B | $7.55B | $7.64B | $8.25B | $7.51B | $7.38B | — | $7.15B |
| Debt | $3.59B | $4.16B | $4.02B | $4.20B | $4.06B | $3.78B | $3.64B | $4.08B | $4.15B | $4.18B | — | $3.91B |
| Total liabilities | $5.96B | $6.43B | $6.34B | $6.56B | $6.27B | $6.47B | $6.53B | $7.51B | $6.91B | $7.13B | — | $7.20B |
| Shareholders' equity | $100.0M | $860.0M | $1.01B | $689.0M | $813.0M | $1.08B | $1.11B | $737.0M | $604.0M | $250.0M | — | −$49.0M |
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $594.0M | $640.0M | $1.14B | $650.0M | $807.0M | $814.0M | $755.0M | $556.0M | −$633.0M | $264.0M | $397.0M | — |
| Capital spending | $338.0M | $411.0M | $498.0M | $481.0M | $267.0M | $277.0M | $307.0M | $370.0M | $360.0M | $213.0M | $179.0M | — |
| Free cash flow | $256.0M | $229.0M | $642.0M | $169.0M | $540.0M | $537.0M | $448.0M | $186.0M | −$993.0M | $51.0M | $218.0M | — |
| Buybacks | $0 | $106.0M | $644.0M | $322.0M | $0 | $173.0M | $495.0M | $69.0M | — | — | — | — |
| Dividends | $22.0M | $22.0M | $148.0M | $164.0M | $164.0M | $164.0M | $154.0M | $149.0M | $148.0M | $78.0M | $54.0M | — |
| Returned to shareholders | $22.0M | $128.0M | $792.0M | $486.0M | $164.0M | $337.0M | $649.0M | $218.0M | $148.0M | $78.0M | $54.0M | — |
| Stock-based pay | $19.0M | $29.0M | $24.0M | $19.0M | $16.0M | $34.0M | $27.0M | $18.0M | $15.0M | $21.0M | $23.0M | — |
Every column links to the filing it comes from on EDGAR. Last 12 months adds the latest year to date to the last 10-K and takes away the same months a year earlier. Debt is long-term debt including the part due within a year. A dash means the company did not report that line in a form we can read, never a zero. Market cap uses the latest closing price and the share count from the cover of the latest filing. How we count
$1.92B at $12.74 a share, with 150,498,995 shares outstanding as of Jul 30, 2026, from the cover of its latest SEC filing.
Revenue of $5.80B and net income of -$304.0M in the last 12 months to Jun 2026.
Chemours reported $3.91B of debt and $671.0M of cash and equivalents on its balance sheet in Jun 2026.
Yes. Operating cash flow minus capital spending was $218.0M in the last 12 months to Jun 2026.
$78.0M in buybacks and dividends in fiscal 2025, from the cash flow statement.
Free. Your email goes to Substack, which runs the newsletter. Privacy